Ana Bosch Campos
11 – 20 of 23
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer
(
- Contribution to journal › Article
-
Mark
Molecular analyses of triple-negative breast cancer in the young and elderly
(
- Contribution to journal › Article
-
Mark
Prognostic impact of tumor-specific insulin-like growth factor binding protein 7 (IGFBP7) levels in breast cancer : A prospective cohort study
(
- Contribution to journal › Article
- 2020
-
Mark
Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers
(
- Contribution to journal › Article
-
Mark
Whole-genome sequencing of triple negative breast cancers in a standard population-based clinical setting
2020) UK Interdisciplinary Breast Cancer Symposium 2020 In Breast Cancer Research and Treatment 180. p.531-532(
- Contribution to journal › Published meeting abstract
- 2019
-
Mark
Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study
(
- Contribution to journal › Article
-
Mark
The X-Linked DDX3X RNA Helicase Dictates Translation Reprogramming and Metastasis in Melanoma
(
- Contribution to journal › Article
- 2018
-
Mark
The strategy of piking a target : What is aktually most effective?
(
- Contribution to journal › Article
- 2017
-
Mark
Strategies to design clinical studies to identify predictive biomarkers in cancer research
(
- Contribution to journal › Scientific review
- 2016
-
Mark
High expression of cholesterol biosynthesis genes is associated with resistance to statin treatment and inferior survival in breast cancer
(
- Contribution to journal › Article